MYLAN, LDA secures contract for Antineoplastic and immunomodulating agents - 2023/0491 - ACETATO DE GLATIRAMERO [40 MG/ 1 ML; SOL INJ; SERINGA]

Portugal, Sept. 23 -- Portugal based MYLAN, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for Antineoplastic and immunomodulating agents - 2023/0491 - ACETATO DE GLATIRAMERO [40 MG/ 1 ML; SOL INJ; SERINGA]. The value of the contract is worth 13708800 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....